# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-24-002041
Filing Date
2024-12-23
Accepted
2024-12-23 16:30:33
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | e6219_10-k.htm iXBRL | 10-K | 1282045
2 | EXHIBIT 19.1 | e6219_ex19-1.htm | EX-19.1 | 27450
3 | EXHIBIT 21.1 | e6219_ex21-1.htm | EX-21.1 | 3864
4 | EXHIBIT 23.1 | e6219_ex23-1.htm | EX-23.1 | 2656
5 | EXHIBIT 31.1 | e6219_ex31-1.htm | EX-31.1 | 16197
6 | EXHIBIT 31.2 | e6219_ex31-2.htm | EX-31.2 | 13930
7 | EXHIBIT 32.1 | e6219_ex32-1.htm | EX-32.1 | 7064
13 | GRAPHIC | image_001.jpg | GRAPHIC | 292036
14 | GRAPHIC | image_002.jpg | GRAPHIC | 94445
| Complete submission text file | 0001731122-24-002041.txt |  | 5505180

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | avxl-20240930.xsd | EX-101.SCH | 32232
9 | XBRL CALCULATION FILE | avxl-20240930_cal.xml | EX-101.CAL | 29363
10 | XBRL DEFINITION FILE | avxl-20240930_def.xml | EX-101.DEF | 94830
11 | XBRL LABEL FILE | avxl-20240930_lab.xml | EX-101.LAB | 290122
12 | XBRL PRESENTATION FILE | avxl-20240930_pre.xml | EX-101.PRE | 223978
60 | EXTRACTED XBRL INSTANCE DOCUMENT | e6219_10-k_htm.xml | XML | 504661

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-37606 | Film No.: 241574057
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)